OSI PHARMACEUTICALS INC
10-Q, EX-27, 2000-08-14
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: OSI PHARMACEUTICALS INC, 10-Q, EX-10.1, 2000-08-14
Next: SHELTER PROPERTIES VI LIMITED PARTNERSHIP, 10QSB, 2000-08-14



<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1
<CURRENCY> US DOLLARS

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          SEP-30-2000
<PERIOD-START>                             OCT-01-1999
<PERIOD-END>                               JUN-30-2000
<EXCHANGE-RATE>                                      1
<CASH>                                      66,412,771
<SECURITIES>                                16,319,161
<RECEIVABLES>                                  250,659
<ALLOWANCES>                                    27,289
<INVENTORY>                                          0
<CURRENT-ASSETS>                            84,398,642
<PP&E>                                      26,889,256
<DEPRECIATION>                              17,830,507
<TOTAL-ASSETS>                              97,372,240
<CURRENT-LIABILITIES>                        4,457,264
<BONDS>                                              0
                                0
                                          0
<COMMON>                                       274,252
<OTHER-SE>                                  90,065,288
<TOTAL-LIABILITY-AND-EQUITY>                97,372,240
<SALES>                                        463,989
<TOTAL-REVENUES>                            22,232,929
<CGS>                                          643,876
<TOTAL-COSTS>                               32,727,556
<OTHER-EXPENSES>                                75,867
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              25,242
<INCOME-PRETAX>                            (4,491,735)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (4,491,735)
<EPS-BASIC>                                     (0.19)
<EPS-DILUTED>                                   (0.19)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission